Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000057098 | SCV001249013 | pathogenic | not provided | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003389393 | SCV004101668 | pathogenic | Epidermolytic hyperkeratosis 1 | 2023-08-17 | criteria provided, single submitter | clinical testing | The KRT1 c.591+1G>C variant results in a substitution at the consensus splice donor site and has been shown to cause an in-frame deletion of a portion of the highly conserved helix initiation motif of the alpha-helical rod domain through the use of a cryptic splice site. This region is critical for keratin intermediate filament assembly and function (PMID: 14708600). This variant has been observed in an individual with a phenotype consistent with epidermolytic ichthyosis (PMID: 14708600). Other variants affecting the same, or neighboring nucleotide have also been reported in individuals with a phenotype consistent with epidermolytic ichthyosis (PMID: 14708600; 12406346). This variant is not observed in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database. Based on the available evidence, the c.591+1G>C variant is classified as pathogenic for epidermolytic ichthyosis. |
Epithelial Biology; Institute of Medical Biology, |
RCV000057098 | SCV000088211 | not provided | not provided | no assertion provided | not provided |